The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation information

Print

Poster Presentation

(E) Pharmaceutical Health Care and Sciences

[26PO10-pm1] Pathological models-1/Genes and gene therapy of diseases/Clinical biochemistry/Others

Sat. Mar 26, 2022 1:30 PM - 3:10 PM [Room PO10] Lounge in front of Room D (Bldg. 1: 4F)

1:30 PM - 3:10 PM

[26PO10-pm1-10S] Therapeutic effect of high-level expression of type 2 diabetes susceptibility gene “ASB3” in the liver using an improved adenovirus on glucose and lipid metabolism

○Moka Mitsukawa1, Kahori Shimizu1, Misato Miyauchi1, Iori Tokiwa1, Momoka Terada1, Tomoyuki Terada1, Fuminori Sakurai2, Hiroyuki Mizuguchi2,3,4,5, Koji Tomita1, Toru Nishinaka1 (1. Pharm., Osaka Ohtani Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Natl. Inst. Biomed. Innov. Health Nutr., 4. MEIC, Osaka Univ., 5. OTRI, Osaka Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password